Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Scale for the Assessment of Negative Symptoms
Nancy C. Andreasen
PsycTESTS Dataset (1982)
Closed Access | Times Cited: 1887

Showing 1-25 of 1887 citing articles:

The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies.
Roman Kotov, Robert F. Krueger, David Watson, et al.
Journal of Abnormal Psychology (2017) Vol. 126, Iss. 4, pp. 454-477
Open Access | Times Cited: 2479
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver Howes, Robert A. McCutcheon, Ofer Agid, et al.
American Journal of Psychiatry (2016) Vol. 174, Iss. 3, pp. 216-229
Open Access | Times Cited: 907
Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium
Theo G.M. van Erp, Esther Walton, Derrek P. Hibar, et al.
Biological Psychiatry (2018) Vol. 84, Iss. 9, pp. 644-654
Open Access | Times Cited: 806
The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
Ann M. Kring, Raquel E. Gur, Jack J. Blanchard, et al.
American Journal of Psychiatry (2013) Vol. 170, Iss. 2, pp. 165-172
Open Access | Times Cited: 653
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Paolo Fusar‐Poli, Evangelos Papanastasiou, Daniel Ståhl, et al.
Schizophrenia Bulletin (2014) Vol. 41, Iss. 4, pp. 892-899
Open Access | Times Cited: 602
Neural synchrony indexes disordered perception and cognition in schizophrenia
Kevin Spencer, Paul G. Nestor, Ruth Perlmutter, et al.
Proceedings of the National Academy of Sciences (2004) Vol. 101, Iss. 49, pp. 17288-17293
Open Access | Times Cited: 595
D-serine added to antipsychotics for the treatment of schizophrenia
Guochuan Tsai, Pinchen Yang, Li-Chen Chung, et al.
Biological Psychiatry (1998) Vol. 44, Iss. 11, pp. 1081-1089
Closed Access | Times Cited: 561
Clozapinev. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis
Dan Siskind, Lara McCartney, Romi Goldschlager, et al.
The British Journal of Psychiatry (2016) Vol. 209, Iss. 5, pp. 385-392
Open Access | Times Cited: 507
The current conceptualization of negative symptoms in schizophrenia
Stephen R. Marder, Silvana Galderisi
World Psychiatry (2017) Vol. 16, Iss. 1, pp. 14-24
Open Access | Times Cited: 442
Intensive case management for severe mental illness
Marina Dieterich, Claire B Irving, Bert Park, et al.
Cochrane database of systematic reviews (2010)
Open Access | Times Cited: 426
Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome
Gregory P. Strauss, William P. Horan, Brian Kirkpatrick, et al.
Journal of Psychiatric Research (2013) Vol. 47, Iss. 6, pp. 783-790
Open Access | Times Cited: 398
Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for Psychosis
Barnaby Nelson, Hok Pan Yuen, Stephen J. Wood, et al.
JAMA Psychiatry (2013) Vol. 70, Iss. 8, pp. 793-793
Closed Access | Times Cited: 398
A Review of Reward Processing and Motivational Impairment in Schizophrenia
Gregory P. Strauss, James A. Waltz, James M. Gold
Schizophrenia Bulletin (2013) Vol. 40, Iss. Suppl 2, pp. S107-S116
Open Access | Times Cited: 395
Theory of mind in schizophrenia: A critical review
Leigh Harrington, Richard J. Siegert, John McClure
Cognitive Neuropsychiatry (2005) Vol. 10, Iss. 4, pp. 249-286
Closed Access | Times Cited: 375
Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis
Meenakshi Dauwan, Marieke J.H. Begemann, Sophie M. Heringa, et al.
Schizophrenia Bulletin (2015) Vol. 42, Iss. 3, pp. 588-599
Open Access | Times Cited: 341
AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial
Tom Craig, Mar Rus‐Calafell, Thomas Ward, et al.
The Lancet Psychiatry (2017) Vol. 5, Iss. 1, pp. 31-40
Open Access | Times Cited: 333
Relapse Duration, Treatment Intensity, and Brain Tissue Loss in Schizophrenia: A Prospective Longitudinal MRI Study
Nancy C. Andreasen, Dawei Liu, Steven Ziebell, et al.
American Journal of Psychiatry (2013) Vol. 170, Iss. 6, pp. 609-615
Open Access | Times Cited: 317
Evidence of a dimensional relationship between schizotypy and schizophrenia: A systematic review
Margaret Tasma Nelson, Marc L. Seal, Christos Pantelis, et al.
Neuroscience & Biobehavioral Reviews (2013) Vol. 37, Iss. 3, pp. 317-327
Closed Access | Times Cited: 313
Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis
Jianping Zhang, Juan A. Gallego, Delbert G. Robinson, et al.
The International Journal of Neuropsychopharmacology (2012) Vol. 16, Iss. 6, pp. 1205-1218
Open Access | Times Cited: 304
Outcomes of Nontransitioned Cases in a Sample at Ultra-High Risk for Psychosis
Ashleigh Lin, Stephen J. Wood, Barnaby Nelson, et al.
American Journal of Psychiatry (2014) Vol. 172, Iss. 3, pp. 249-258
Open Access | Times Cited: 268
Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research
Esther Walton, Johanna Haß, Jingyu Liu, et al.
Schizophrenia Bulletin (2015) Vol. 42, Iss. 2, pp. 406-414
Open Access | Times Cited: 264
Autism Spectrum Disorders and Schizophrenia: Meta-Analysis of the Neural Correlates of Social Cognition
Gisela Sugranyes, Marinos Kyriakopoulos, Richard Corrigall, et al.
PLoS ONE (2011) Vol. 6, Iss. 10, pp. e25322-e25322
Open Access | Times Cited: 263
Spontaneous Gamma Activity in Schizophrenia
Yoji Hirano, Naoya Oribe, Shigenobu Kanba, et al.
JAMA Psychiatry (2015) Vol. 72, Iss. 8, pp. 813-813
Open Access | Times Cited: 244
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
Patrick D. McGorry, Barnaby Nelson, Connie Markulev, et al.
JAMA Psychiatry (2016) Vol. 74, Iss. 1, pp. 19-19
Open Access | Times Cited: 242
Predictors of functional recovery in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies
Olga Santesteban‐Echarri, Mercedes Paíno, Simon Rice, et al.
Clinical Psychology Review (2017) Vol. 58, pp. 59-75
Open Access | Times Cited: 233
Page 1 - Next Page

Scroll to top